Loading company…
Weave Bio provides regulatory document automation for biotech and pharmaceutical companies.
Weave Bio offers tools for preparing investigational new drug applications and clinical trial submissions. Its platform also supports AI-assisted drafting, source verification, and document review. Founded in 2022, the company is based in San Francisco, US. In October 2025, it raised USD 20 million in series A funding led by US Venture Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in